Literature DB >> 21320469

The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.

Myung-Suk Choi1, Sang-Hyun Min, Haiyoung Jung, Ju Dong Lee, Tae Ho Lee, Heung Kyu Lee, Ook-Joon Yoo.   

Abstract

The phosphatase of regenerating liver-3 (PRL-3) is a member of protein tyrosine phosphatases and whose deregulation is implicated in tumorigenesis and metastasis of many cancers. However, the underlying mechanism by which PRL-3 is regulated is not known. In this study, we identified the peptidyl prolyl cis/trans isomerase FK506-binding protein 38 (FKBP38) as an interacting protein of PRL-3 using a yeast two-hybrid system. FKBP38 specifically binds to PRL-3 in vivo, and that the N-terminal region of FKBP38 is crucial for binding with PRL-3. FKBP38 overexpression reduces endogenous PRL-3 expression levels, whereas the depletion of FKBP38 by siRNA increases the level of PRL-3 protein. Moreover, FKBP38 promotes degradation of endogenous PRL-3 protein via protein-proteasome pathway. Furthermore, FKBP38 suppresses PRL-3-mediated p53 activity and cell proliferation. These results demonstrate that FKBP38 is a novel regulator of the oncogenic protein PRL-3 abundance and that alteration in the stability of PRL-3 can have a dramatic impact on cell proliferation. Thus, FKBP38 may play a critical role in tumorigenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320469     DOI: 10.1016/j.bbrc.2011.02.037

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation.

Authors:  Fu-Fei Hsu; Yi-Tai Chou; Ming-Tsai Chiang; Fu-An Li; Chi-Tai Yeh; Wei-Hwa Lee; Lee-Young Chau
Journal:  Oncogene       Date:  2018-10-22       Impact factor: 9.867

2.  VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C.

Authors:  Jianliang Xu; Shaoxian Cao; Lu Wang; Rui Xu; Gong Chen; Qiang Xu
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

3.  Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1.

Authors:  Carmen M Dumaual; Boyd A Steere; Chad D Walls; Mu Wang; Zhong-Yin Zhang; Stephen K Randall
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

Review 4.  Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.

Authors:  Teresa Rubio; Maja Köhn
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

5.  Identification of proteins suppressing the functions of oncogenic phosphatase of regenerating liver 1 and 3.

Authors:  Ju-Dong Lee; Haiyoung Jung; Sang-Hyun Min
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

6.  Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion.

Authors:  James J Fiordalisi; Brian J Dewar; Lee M Graves; James P Madigan; Adrienne D Cox
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

7.  Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia.

Authors:  Shuang Qu; Bin Liu; Xiaoling Guo; Hongshun Shi; Meifeng Zhou; Li Li; Shulan Yang; Xiuzhen Tong; Haihe Wang
Journal:  Cancer       Date:  2014-04-15       Impact factor: 6.860

8.  PRL-3 disrupts epithelial architecture by altering the post-mitotic midbody position.

Authors:  Pablo Luján; Giulia Varsano; Teresa Rubio; Marco L Hennrich; Timo Sachsenheimer; Manuel Gálvez-Santisteban; Fernando Martín-Belmonte; Anne-Claude Gavin; Britta Brügger; Maja Köhn
Journal:  J Cell Sci       Date:  2016-09-21       Impact factor: 5.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.